In contrast, human epididymis protein (HE4), a new marker for the diagnosis of ovarian cancer, particularly early-stage ovarian cancer, has high specificity and is present in very high levels in the serum of patients with ovarian cancer [7]. This evidence concerns the gene WFDC2 and ovarian carcinoma.